Mir A. Imran - 16 Dec 2024 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
Svai Sanford. Attorney-in-Fact for Mir Imran
Issuer symbol
RANI
Transactions as of
16 Dec 2024
Transactions value $
$0
Form type
4
Filing time
17 Dec 2024, 17:00:04 UTC
Previous filing
30 May 2024
Next filing
30 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Stock Option (Right to Buy) Disposed to Issuer -101K -100% 0 16 Dec 2024 Class A Common Stock 101K $2.84 Direct F1
transaction RANI Stock Option (Right to Buy) Award +101K 101K 16 Dec 2024 Class A Common Stock 101K $4.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.